Silver RM - Search Results

1

Antinuclear antibody-negative systemic sclerosis.

Salazar GA, Assassi S, Wigley F, Hummers L, Varga J, Hinchcliff M, Khanna D, Schiopu E, Phillips K, Furst DE, Steen V, Baron M, Hudson M, Taillefer SS, Pope J, Jones N, Docherty P, Khalidi NA, Robinson D, Simms RW, Silver RM, Frech TM, Fessler BJ, Molitor JA, Fritzler MJ, Segal BM, Al-Kassab F, Perry M, Yang J, Zamanian S, Reveille JD, Arnett FC, Pedroza C, Mayes MD. Salazar GA, et al. Among authors: silver rm. Semin Arthritis Rheum. 2015 Jun;44(6):680-6. doi: 10.1016/j.semarthrit.2014.11.006. Epub 2014 Nov 28. Semin Arthritis Rheum. 2015. PMID: 25578738 Free PMC article.

2

Clinical aspects of systemic sclerosis (scleroderma).

Silver RM. Silver RM. Ann Rheum Dis. 1991 Nov;50 Suppl 4(Suppl 4):854-61. doi: 10.1136/ard.50.suppl_4.854. Ann Rheum Dis. 1991. PMID: 1750797 Free PMC article. Review. No abstract available.

3

Lung disease associated with progressive systemic sclerosis. Assessment of interlobar variation by bronchoalveolar lavage and comparison with noninvasive evaluation of disease activity.

Miller KS, Smith EA, Kinsella M, Schabel SI, Silver RM. Miller KS, et al. Among authors: silver rm. Am Rev Respir Dis. 1990 Feb;141(2):301-6. doi: 10.1164/ajrccm/141.2.301. Am Rev Respir Dis. 1990. PMID: 2301848

4

Lung involvement in systemic sclerosis.

Silver RM, Miller KS. Silver RM, et al. Rheum Dis Clin North Am. 1990 Feb;16(1):199-216. Rheum Dis Clin North Am. 1990. PMID: 2406808 Review.

5

A strategy for determining the pathogenesis of systemic sclerosis. Is transforming growth factor beta the answer?

Leroy EC, Smith EA, Kahaleh MB, Trojanowska M, Silver RM. Leroy EC, et al. Among authors: silver rm. Arthritis Rheum. 1989 Jul;32(7):817-25. Arthritis Rheum. 1989. PMID: 2665755 Review. No abstract available.

6

Progressive systemic sclerosis sine scleroderma presenting as pulmonary interstitial fibrosis.

Lomeo RM, Cornella RJ, Schabel SI, Silver RM. Lomeo RM, et al. Among authors: silver rm. Am J Med. 1989 Nov;87(5):525-7. doi: 10.1016/s0002-9343(89)80608-4. Am J Med. 1989. PMID: 2683765 Review.

7

Spontaneous production of fibronectin by alveolar macrophages in patients with scleroderma.

Kinsella MB, Smith EA, Miller KS, LeRoy EC, Silver RM. Kinsella MB, et al. Among authors: silver rm. Arthritis Rheum. 1989 May;32(5):577-83. doi: 10.1002/anr.1780320511. Arthritis Rheum. 1989. PMID: 2719731

8

Interstitial lung disease of systemic sclerosis.

Silver RM. Silver RM. Int Rev Immunol. 1995;12(2-4):281-91. doi: 10.3109/08830189509056718. Int Rev Immunol. 1995. PMID: 7650424 Review.

9

Systemic sclerosis (scleroderma). Clinical management of its major complications.

Legerton CW 3rd, Smith EA, Silver RM. Legerton CW 3rd, et al. Among authors: silver rm. Rheum Dis Clin North Am. 1995 Feb;21(1):203-16. Rheum Dis Clin North Am. 1995. PMID: 7732169 Review.

10

Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease.

Silver RM, Warrick JH, Kinsella MB, Staudt LS, Baumann MH, Strange C. Silver RM, et al. J Rheumatol. 1993 May;20(5):838-44. J Rheumatol. 1993. PMID: 8336309 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

724 results

Search Page